[Latent alcoholic hepatopathy: diagnostic criteria, prognostic evaluation and therapeutic guidelines].
D002392:Catechin / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008082:Lipotropic Agents / Q000627:therapeutic use; D008108:Liver Diseases, Alcoholic / Q000175:diagnosis* / Q000178:diet therapy / Q000188:drug therapy; D011379:Prognosis; D011720:Pyrazoles / Q000627:therapeutic use; D012436:S-Adenosylmethionine / Q000627:therapeutic use; D012838:Silymarin / Q000627:therapeutic use; D013438:Sulfhydryl Compounds / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D008082:Lipotropic Agents; D011720:Pyrazoles; D012838:Silymarin; D013438:Sulfhydryl Compounds; D014815:Vitamins; D012436:S-Adenosylmethionine; D002392:Catechin; D002955:Leucovorin
L'epatopatia alcoolica latente: criteri diagnostici, valutazione prognostica, indirizzi terapeutici.